Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer

Author:

Hussain Maha1ORCID,Mateo Joaquin1,Fizazi Karim1,Saad Fred1,Shore Neal1,Sandhu Shahneen1,Chi Kim N.1,Sartor Oliver1ORCID,Agarwal Neeraj1,Olmos David1,Thiery-Vuillemin Antoine1,Twardowski Przemyslaw1,Roubaud Guilhem1,Özgüroğlu Mustafa1,Kang Jinyu1,Burgents Joseph1,Gresty Christopher1,Corcoran Claire1,Adelman Carrie A.1,de Bono Johann1ORCID

Affiliation:

1. From the Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago (M.H.); Vall d’Hebron Institute of Oncology and Vall d’Hebron University Hospital, Barcelona (J.M.), the Spanish National Cancer Research Center, Madrid (D.O.), and Instituto de Investigación Biomédica de Málaga, Málaga (D.O.) — all in Spain; Institut Gustave Roussy, University of Paris Saclay, Villejuif (K.F.), the Department of Medical Oncology, Centre Hospitalier Universitaire Besançon,...

Funder

AstraZeneca

Merck Sharp & Dohme

Publisher

Massachusetts Medical Society

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3